Phase 2 Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have developed moderate to severe kidney injury (stages 2 or 3) as a result of heart surgery
Who may not be able to join:
- People who have long-term (chronic) kidney disease
- People whose heart is not pumping well enough (with an ejection fraction below 45%, meaning the heart is significantly weakened)
- People who have advanced liver scarring (cirrhosis rated as Child B or C)
- People who have an active infection
- People who are actively bleeding
- People who have been taking immune-suppressing medications long-term, except for azacitidine
- People who have an active cancer, other than acute leukemia or a condition called myelodysplastic syndrome
- People who have low white blood cell counts, low red blood cell counts, or low platelet counts
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yu Hsiang Chou, PhD, National Taiwan University Hospital
Phone: 886-23123456
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Renal composite outcome
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.